How does Glimepiride interact with DPP-4 inhibitors when used in combination therapy? Are there any synergistic benefits or risks to consider?
Lakshya KumarExplorer
How does Glimepiride interact with DPP-4 inhibitors in combination therapy?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Glimepiride, a sulfonylurea, enhances insulin secretion, while DPP-4 inhibitors prolong incretin effect. Together, they can improve glycemic control but may increase hypoglycemia risk.